Bristol-Myers Squibb Latest To License DPP-4 Patents From OSI
OSI "owns the patent estate" on DPP-4 inhibitors and has licensed the medical use patents to Merck, Novartis and others.
OSI "owns the patent estate" on DPP-4 inhibitors and has licensed the medical use patents to Merck, Novartis and others.